Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyquaternium-1 is a synthetic polycationic polymer belonging to the quaternary ammonium compound class, used primarily as a **preservative** in ophthalmic (eye drop) formulations and some contact lens solutions[1][2][4]. It inhibits the growth of microbial contaminants in multi-dose topical solutions, providing broad-spectrum antimicrobial activity with relatively low cytotoxicity compared to older preservatives like benzalkonium chloride[2][4]. In addition to its ophthalmic use, it is employed in personal care products (e.g. hair conditioners, shampoos, and skin lotions) as a film-forming and antistatic agent, where its positive charge allows it to neutralize negatively charged surfaces like hair and skin, thus helping to smooth and condition these substrates[3][4][5]. Polyquaternium-1 does not have pharmacological activity via a biological receptor; its function is based on physical-chemical antimicrobial action due to the presence of permanently charged quaternary ammonium groups in its polymer backbone[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyquaternium-1.